Hi Quiltman,
Excellent informative post. Did you know this? it's been common knowledge for a while but sometimes things are left out of HC for a reason or its sometimes a timing issue.
Lucas Montarce, who serves as a board member of Elanco, is also the Executive Vice President and Chief Financial Officer of Eli Lilly. He previously held the position of Vice President, Finance, and Global Chief Financial Officer at Elanco Health during his tenure at Lilly.
Thus, a valid link Elanco/ Eli Lilly/ Neurizon nee Pharmaust.
https://investor.lilly.com/news-releases/news-release-details/lilly-appoints-lucas-montarce-executive-vice-president-and-chief
Lilly does not have a direct role in the HEALEY ALS Platform Trial, but its broader research strategy aligns with the trial's innovative and patient-centric approach. Lilly emphasizes adaptive trial designs, patient engagement, and clinical trial diversity to enhance efficiency and inclusivity in drug development. These principles mirror the HEALEY trial's goals of accelerating ALS treatment discovery through shared infrastructure, adaptive protocols, and reduced placebo.
Reference : Perplexity Ai
Eli Lilly has spent significant dollars since 2020 to capture a drug. So far it's all pre clinical !
Kpax
- Forums
- ASX - By Stock
- NUZ
- Ann: Neurizon Files IND Application to Support HEALEY ALS Trial
NUZ
neurizon therapeutics limited
Add to My Watchlist
3.03%
!
17.0¢

Ann: Neurizon Files IND Application to Support HEALEY ALS Trial, page-80
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $83.69M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.5¢ | $31.76K | 188.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 29214 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 59381 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 29214 | 0.165 |
3 | 224000 | 0.160 |
4 | 43819 | 0.155 |
2 | 220000 | 0.150 |
4 | 865247 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 59381 | 1 |
0.175 | 176045 | 3 |
0.180 | 94474 | 1 |
0.185 | 125000 | 3 |
0.190 | 24925 | 2 |
Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online